(Q34969240)

5 August 2017

1 reference

title

Current management and prognostic factors for adult ependymoma (English)

1 reference

5 August 2017

1 reference

1 reference

2

Alba A Brandes

1 reference

5 August 2017

Michele Reni

1

1 reference

5 August 2017

publication date

1 October 2002

1 reference

Expert Review of Anticancer Therapy

5 August 2017

published in

1 reference

5 August 2017

volume

2

1 reference

5 August 2017

issue

5

1 reference

5 August 2017

page(s)

537-545

1 reference

Ependymomas of the third ventricle

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.5.537

Supratentorial ependymomas. Neuroimaging and clinicopathological correlation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.5.537

Infratentorial ependymomas in childhood: prognostic factors and treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.5.537

Histologic prognostic factors in ependymoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.5.537

Natural simian virus 40 strains are present in human choroid plexus and ependymoma tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.5.537

21 January 2018

Prognosis of ependymoma.

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.5.537

Ependymomas: MIB-1 proliferation index and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.5.537

Gain of 1q and loss of 22 are the most common changes detected by comparative genomic hybridisation in paediatric ependymoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.5.537

Molecular analysis of genetic changes in ependymomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.5.537

Intracranial ependymomas: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.5.537

Frequent type 2 neurofibromatosis gene transcript mutations in sporadic intramedullary spinal cord ependymomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.5.537

Ependymoma: results, prognostic factors and treatment recommendations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.5.537

The results of radiotherapy for ependymomas: the Mayo Clinic experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.5.537

Postoperative radiotherapy of spinal and intracranial ependymomas: analysis of prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.5.537

Ependymomas: results of radiation treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.5.537

Postoperative Irradiation of Brain Ependymomas: Analysis of 33 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.5.537

The clinical and prognostic relevance of grading in intracranial ependymomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.5.537

Postoperative radiotherapy of intracranial ependymoma in pediatric and adult patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.5.537

Ependymomas. Factors in clinical and diagnostic staging

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.5.537

Lack of histopathological correlation of malignant ependymomas with postoperative survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.5.537

Intracranial ependymoma long term outcome, patterns of failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.5.537

Intracranial ependymomas: results of treatment with partial or whole brain irradiation without spinal irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.5.537

The significance of radiotherapy treatment duration in intracranial ependymoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.5.537

Anaplastic ependymoma: treatment of pediatric patients with or without craniospinal radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.5.537

Intracranial ependymomas in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.5.537

Radiation therapy and the management of intramedullary spinal cord tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.5.537

Treatment of intracranial ependymoma by surgery alone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.5.537

Intramedullary ependymomas: clinical presentation, surgical treatment strategies and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.5.537

Ependymoma: a follow-up study of 101 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.5.537

Posterior fossa ependymomas in adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.5.537

The local field in infratentorial ependymoma: does the entire posterior fossa need to be treated?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.5.537

Improved survival in cases of intracranial ependymoma after radiation therapy. Late report and recommendations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.5.537

A comparative study of ependymomas by site of origin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.5.537

Preliminary results from a Phase II trail of conformal radiation therapy for pediatric patients with localised low-grade astrocytoma and ependymoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.5.537

Efficacy and feasibility of stereotactic radiosurgery in the primary management of unfavorable pediatric ependymoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.5.537

Adjuvant stereotactic radiosurgery for anaplastic ependymoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.5.537

Chemotherapy for intracranial ependymomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.5.537

Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.5.537

Survival following intensive chemotherapy with bone marrow reconstitution for children with recurrent intracranial ependymoma--a report of the Children's Cancer Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.5.537

A high-dose busulfan-thiotepa combination followed by autologous bone marrow transplantation in childhood recurrent ependymoma. A phase-II study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.5.537

Topotecan for the treatment of recurrent or progressive central nervous system tumors - a pediatric oncology group phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.5.537

21 January 2018

Identifiers

DOI

10.1586/14737140.2.5.537

1 reference

5 August 2017

1 reference